Insider Buying: Ultralife (NASDAQ:ULBI) Director Acquires $162,951.60 in Stock

Ultralife Corporation (NASDAQ:ULBI) Director Bradford Whitmore purchased 28,588 shares of the business’s stock in a transaction on Tuesday, December 16th. The shares were acquired at an average price of $5.70 per share, with a total value of $162,951.60. Following the purchase, the director owned 1,235,631 shares of the company’s stock, valued at approximately $7,043,096.70. This trade represents a 2.37% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Ultralife Stock Down 1.9%

NASDAQ ULBI opened at $5.80 on Friday. Ultralife Corporation has a 1-year low of $4.07 and a 1-year high of $9.52. The company has a market capitalization of $96.57 million, a price-to-earnings ratio of 58.00 and a beta of 0.88. The stock’s 50 day moving average is $6.13 and its two-hundred day moving average is $7.09. The company has a current ratio of 2.99, a quick ratio of 1.42 and a debt-to-equity ratio of 0.34.

Ultralife (NASDAQ:ULBI) last posted its earnings results on Monday, November 17th. The technology company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.21 by ($0.28). The company had revenue of $43.37 million for the quarter, compared to the consensus estimate of $53.00 million. Ultralife had a return on equity of 1.66% and a net margin of 0.92%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of Ultralife in a research note on Monday. Wall Street Zen lowered shares of Ultralife from a “strong-buy” rating to a “hold” rating in a research report on Saturday, September 13th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Institutional Trading of Ultralife

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Susquehanna International Group LLP lifted its position in Ultralife by 100.7% during the 3rd quarter. Susquehanna International Group LLP now owns 27,670 shares of the technology company’s stock worth $189,000 after buying an additional 13,882 shares in the last quarter. Prelude Capital Management LLC bought a new position in shares of Ultralife in the third quarter worth about $71,000. Citadel Advisors LLC lifted its position in shares of Ultralife by 78.9% during the third quarter. Citadel Advisors LLC now owns 80,921 shares of the technology company’s stock worth $552,000 after purchasing an additional 35,695 shares in the last quarter. Bank of America Corp DE grew its stake in shares of Ultralife by 39.9% during the third quarter. Bank of America Corp DE now owns 13,351 shares of the technology company’s stock valued at $91,000 after purchasing an additional 3,810 shares during the last quarter. Finally, Ancora Advisors LLC grew its stake in shares of Ultralife by 24.3% during the third quarter. Ancora Advisors LLC now owns 105,321 shares of the technology company’s stock valued at $718,000 after purchasing an additional 20,562 shares during the last quarter. 30.68% of the stock is currently owned by institutional investors and hedge funds.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.